Login to Your Account

Structural GenomiX Signs First FAST Platform Partner: Serono

By Karen Pihl-Carey

Wednesday, March 24, 2004
In a deal worth up to $68 million, Structural GenomiX agreed to use its FAST drug discovery technology with Serono SA to develop small-molecule therapeutics. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription